Kevin B Zucker Dpm Pc | |
1311 Madison Dr, Buffalo Grove, IL 60089-6827 | |
(847) 821-0743 | |
(847) 821-1421 |
Full Name | Kevin B Zucker Dpm Pc |
---|---|
Type | Facility |
Speciality | Podiatrist |
Location | 1311 Madison Dr, Buffalo Grove, Illinois |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366505109 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | (Illinois) | Primary |
Provider Name | Kevin B Zucker |
---|---|
Provider Type | Practitioner - Podiatry |
Provider Identifiers | NPI Number: 1497736383 PECOS PAC ID: 0345343109 Enrollment ID: I20070315000166 |
News Archive
Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at Imperial College Healthcare NHS Trust, which specialises in In Vitro Diagnostics, explained: "Correct placement of NG tubes is vital, as accidental insertion of the tube into the lung instead of the gut can have serious consequences.
Despite the fact that clogged arteries in the legs usually mean clogged arteries near the heart, doctors often fail to give heart-protecting drugs to people with severe leg blood vessel blockages, a new University of Michigan-led study finds.
Researchers have identified the first two core genes that regulate the amount of deep sleep and dreaming, a key development they believe will lead to the discovery of a network of related genes controlling sleep.
In a Baltimore Sun opinion piece, Richard Santos - president and CEO of IMA World Health, a non-profit that provides health care services and supplies - describes what he sees as the top three priorities for the rebuilding of Haiti, beginning with healthcare, which he describes as " foundational to all else." He continues, "Development groups have experience setting up basic health care systems in South Sudan, the Democratic Republic of Congo and other difficult environments.
GENFIT, today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to the unexpected rate of resolution of NASH in patients randomized to placebo who had early NASH (NAS of 3, placebo response rate>57%), along with the high number of sites for a limited sample size, the study as initially designed did not enable the trial to meet directly the primary endpoint.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Kevin B Zucker Dpm Pc 1311 Madison Dr, Buffalo Grove, IL 60089-6827 Ph: (847) 821-0743 | Kevin B Zucker Dpm Pc 1311 Madison Dr, Buffalo Grove, IL 60089-6827 Ph: (847) 821-0743 |
News Archive
Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at Imperial College Healthcare NHS Trust, which specialises in In Vitro Diagnostics, explained: "Correct placement of NG tubes is vital, as accidental insertion of the tube into the lung instead of the gut can have serious consequences.
Despite the fact that clogged arteries in the legs usually mean clogged arteries near the heart, doctors often fail to give heart-protecting drugs to people with severe leg blood vessel blockages, a new University of Michigan-led study finds.
Researchers have identified the first two core genes that regulate the amount of deep sleep and dreaming, a key development they believe will lead to the discovery of a network of related genes controlling sleep.
In a Baltimore Sun opinion piece, Richard Santos - president and CEO of IMA World Health, a non-profit that provides health care services and supplies - describes what he sees as the top three priorities for the rebuilding of Haiti, beginning with healthcare, which he describes as " foundational to all else." He continues, "Development groups have experience setting up basic health care systems in South Sudan, the Democratic Republic of Congo and other difficult environments.
GENFIT, today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to the unexpected rate of resolution of NASH in patients randomized to placebo who had early NASH (NAS of 3, placebo response rate>57%), along with the high number of sites for a limited sample size, the study as initially designed did not enable the trial to meet directly the primary endpoint.
› Verified 4 days ago
Complete Foot Care Podiatrist Medicare: Medicare Enrolled Practice Location: 981 Pinetree Cir S, Buffalo Grove, IL 60089 Phone: 847-541-2922 Fax: 847-541-2990 | |
Dr. David Bruce Scott, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2100 E Lake Cook Rd, Suite 1100, Buffalo Grove, IL 60089 Phone: 800-317-0711 Fax: 800-434-7113 | |
Dr. Christina Giotis Sarantopoulos, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 355 W Dundee Rd Ste 110, Buffalo Grove, IL 60089 Phone: 847-541-4878 Fax: 847-520-0500 | |
Dr. Lynette Mahoney, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 404 Mchenry Rd, Buffalo Grove, IL 60089 Phone: 847-285-4200 Fax: 847-885-0130 | |
Dr. Robert K Brogadir, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 1306 Madison Dr, Buffalo Grove, IL 60089 Phone: 847-634-3348 Fax: 847-634-6882 | |
Premier Foot & Ankle Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 165 N Arlington Heights Rd, Suite 170, Buffalo Grove, IL 60089 Phone: 847-419-3939 Fax: 224-676-0448 |